0001562180-23-008571.txt : 20231228
0001562180-23-008571.hdr.sgml : 20231228
20231228163837
ACCESSION NUMBER: 0001562180-23-008571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231226
FILED AS OF DATE: 20231228
DATE AS OF CHANGE: 20231228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russell Alan J
CENTRAL INDEX KEY: 0001853529
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 231523116
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE
CITY: BOULDER
STATE: CO
ZIP: 80303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-262-7002
MAIL ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-12-26
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001853529
Russell Alan J
C/O EDGEWISE THERAPEUTICS, INC.
1715 38TH STREET
BOULDER
CO
80301
true
true
false
false
Chief Scientific Officer
false
Common Stock
2023-12-26
4
S
false
172585.00
9.3293
D
3606.00
D
This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price.
/s/ John R. Moore, Attorney-in-Fact for Russell Alan J
2023-12-28